BME
BlackRock Health Sciences Trust
43.30$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | |
| 8.3% | 5.9% | 16.4% | – | – | 0.0% | 6.3% | 11.6% | 5.4% | 16.1% | 5.2% | 6.2% | 10.2% | – | 17.3% | 0.0% | 15.6% | |
| 91.7% | 94.1% | 83.6% | 100.0% | 100.0% | 100.0% | 93.7% | 88.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 82.7% | 100.0% | 84.4% | |
| – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 0.5% | 0.3% | 0.2% | 79.0% | 74.3% | 109.7% | 6.6% | 12.2% | 0.5% | 1.4% | 0.4% | 0.5% | 0.6% | – | 0.9% | 1.5% | 1.2% | |
| 0.0% | 0.0% | 0.0% | 981.1% | 1,807.5% | 1,480.6% | 33.0% | 76.0% | 0.6% | 2.0% | 0.5% | 0.7% | 0.9% | – | 1.1% | 2.6% | -128.5% | |
| 91.2% | 93.8% | 83.4% | 20.6% | 25.4% | -9.8% | 60.7% | -63.0% | 99.4% | 98.0% | 99.5% | 99.3% | 99.1% | – | 24.3% | 97.4% | 212.9% | |
| 0.0% | 0.0% | 0.0% | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.1% | |
| -0.8% | 0.8% | 3.0% | 1,081.1% | 1,907.5% | 1,580.6% | 60.6% | -63.0% | 99.4% | 98.0% | 99.5% | 99.3% | 99.1% | – | 57.4% | 97.4% | 212.9% | |
| 0.0% | 0.0% | 0.0% | 1,060.5% | 1,882.1% | 1,590.5% | 0.0% | 0.0% | 0.3% | -0.7% | 0.8% | 0.1% | 0.0% | – | 5.7% | – | – | |
| 91.2% | 93.8% | -240.8% | 1,081.1% | 1,907.5% | 1,580.6% | 60.6% | -63.0% | 99.4% | 98.0% | 99.5% | 99.3% | 99.1% | – | 57.4% | 97.4% | 212.9% | |
| – | – | – | 1,060.5% | 1,882.1% | 1,590.5% | 60.7% | -62.8% | 99.4% | 98.0% | 99.5% | 99.3% | 99.1% | – | 57.4% | 97.4% | 213.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.